Chief Executive Officer, Beeline Medicines
Appears in 1 story
Leading the company through the Phase 2 to Phase 3 transition
Beeline Medicines' afimetoran, a once-daily oral pill for lupus, met its primary endpoint in a Phase 2 trial. The result moves the biotech into Phase 3 (pivotal) development for two forms of the disease.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
